This will increase the expression of pro-inflammatory factors, such as TNF-α, IFN–γ, and IL-17, and reduce the expression of anti-inflammatory factors, such as IL-10, which will eventually induce local inflammatory response and cause or aggravate IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.